Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Inflammasomes are activated in response to SARS-CoV-2 infection and are associated with COVID-19 severity in patients
Tamara Silva Rodrigues, Keyla Santos Guedes de Sá, Adriene Y. Ishimoto, et al.
The Journal of Experimental Medicine (2020) Vol. 218, Iss. 3
Open Access | Times Cited: 760

Showing 1-25 of 760 citing articles:

Necroptosis, pyroptosis and apoptosis: an intricate game of cell death
Damien Bertheloot, Eicke Latz, Bernardo S. Franklin
Cellular and Molecular Immunology (2021) Vol. 18, Iss. 5, pp. 1106-1121
Open Access | Times Cited: 1405
Diverse functional autoantibodies in patients with COVID-19
Eric Y. Wang, Tianyang Mao, Jon Klein, et al.
Nature (2021) Vol. 595, Iss. 7866, pp. 283-288
Open Access | Times Cited: 835
Endothelial dysfunction and immunothrombosis as key pathogenic mechanisms in COVID-19
Aldo Bonaventura, Alessandra Vecchié, Lorenzo Dagna, et al.
Nature reviews. Immunology (2021) Vol. 21, Iss. 5, pp. 319-329
Open Access | Times Cited: 803
Immune determinants of COVID-19 disease presentation and severity
Petter Brodin
Nature Medicine (2021) Vol. 27, Iss. 1, pp. 28-33
Closed Access | Times Cited: 640
Neutrophil to Lymphocyte Ratio: An Emerging Marker of the Relationships between the Immune System and Diseases
Agata Buonacera, Benedetta Stancanelli, Michele Colaci, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 7, pp. 3636-3636
Open Access | Times Cited: 543
Innate immunity: the first line of defense against SARS-CoV-2
Michael Diamond, Thirumala‐Devi Kanneganti
Nature Immunology (2022) Vol. 23, Iss. 2, pp. 165-176
Open Access | Times Cited: 508
Death by TNF: a road to inflammation
Geert Loo, Mathieu J.M. Bertrand
Nature reviews. Immunology (2022) Vol. 23, Iss. 5, pp. 289-303
Open Access | Times Cited: 495
Early treatment of COVID-19 with anakinra guided by soluble urokinase plasminogen receptor plasma levels: a double-blind, randomized controlled phase 3 trial
Evdoxia Kyriazopoulou, Garyphallia Poulakou, Haralampos Milionis, et al.
Nature Medicine (2021) Vol. 27, Iss. 10, pp. 1752-1760
Open Access | Times Cited: 464
FcγR-mediated SARS-CoV-2 infection of monocytes activates inflammation
Caroline Junqueira, Ângela C. Crespo, Shahin Ranjbar, et al.
Nature (2022) Vol. 606, Iss. 7914, pp. 576-584
Open Access | Times Cited: 464
Inflammasome activation in infected macrophages drives COVID-19 pathology
Esen Sefik, Rihao Qu, Caroline Junqueira, et al.
Nature (2022) Vol. 606, Iss. 7914, pp. 585-593
Open Access | Times Cited: 438
SARS-CoV-2 N protein promotes NLRP3 inflammasome activation to induce hyperinflammation
Pan Pan, Miaomiao Shen, Zhenyang Yu, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 417
COVID-19-associated fungal infections
Martin Hoenigl, Danila Seidel, Rosanne Sprute, et al.
Nature Microbiology (2022) Vol. 7, Iss. 8, pp. 1127-1140
Open Access | Times Cited: 351
Influenza virus and SARS-CoV-2: pathogenesis and host responses in the respiratory tract
Tim Flerlage, David F. Boyd, Victoria Meliopoulos, et al.
Nature Reviews Microbiology (2021) Vol. 19, Iss. 7, pp. 425-441
Open Access | Times Cited: 312
Inflammasome activation at the crux of severe COVID-19
Setu M. Vora, Judy Lieberman, Hao Wu
Nature reviews. Immunology (2021) Vol. 21, Iss. 11, pp. 694-703
Open Access | Times Cited: 294
SARS-CoV-2, COVID-19 and the aging immune system
Juliet M. Bartleson, Dina Radenković, Anthony J. Covarrubias, et al.
Nature Aging (2021) Vol. 1, Iss. 9, pp. 769-782
Open Access | Times Cited: 289
Metformin inhibition of mitochondrial ATP and DNA synthesis abrogates NLRP3 inflammasome activation and pulmonary inflammation
Hongxu Xian, Yuan Liu, A. Nilsson, et al.
Immunity (2021) Vol. 54, Iss. 7, pp. 1463-1477.e11
Open Access | Times Cited: 285
Innate immune and inflammatory responses to SARS-CoV-2: Implications for COVID-19
Shea A. Lowery, Alan Sariol, Stanley Perlman
Cell Host & Microbe (2021) Vol. 29, Iss. 7, pp. 1052-1062
Open Access | Times Cited: 263
Colchicine for community-treated patients with COVID-19 (COLCORONA): a phase 3, randomised, double-blinded, adaptive, placebo-controlled, multicentre trial
Jean‐Claude Tardif, Nadia Bouabdallaoui, Philippe L. L’Allier, et al.
The Lancet Respiratory Medicine (2021) Vol. 9, Iss. 8, pp. 924-932
Open Access | Times Cited: 259
SARS-CoV-2 engages inflammasome and pyroptosis in human primary monocytes
André C. Ferreira, Vinícius Cardoso Soares, Isaclaudia G. Azevedo-Quintanilha, et al.
Cell Death Discovery (2021) Vol. 7, Iss. 1
Open Access | Times Cited: 250
Diabetes, obesity, metabolism, and SARS-CoV-2 infection: the end of the beginning
Daniel J. Drucker
Cell Metabolism (2021) Vol. 33, Iss. 3, pp. 479-498
Open Access | Times Cited: 241
Beneficial effects of colchicine for moderate to severe COVID-19: a randomised, double-blinded, placebo-controlled clinical trial
Maria Isabel Fernandes Lopes, Letícia Pastorelli Bonjorno, Marcela C Giannini, et al.
RMD Open (2021) Vol. 7, Iss. 1, pp. e001455-e001455
Open Access | Times Cited: 230
A 360° view of the inflammasome: Mechanisms of activation, cell death, and diseases
Katherine C. Barnett, Sirui Li, Kaixin Liang, et al.
Cell (2023) Vol. 186, Iss. 11, pp. 2288-2312
Closed Access | Times Cited: 229
SARS-CoV-2-Specific Immune Response and the Pathogenesis of COVID-19
Evgeni Gusev, Alexey Sarapultsev, Л. В. Соломатина, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 3, pp. 1716-1716
Open Access | Times Cited: 224
SARS‐CoV‐2 sensing by RIG‐I and MDA5 links epithelial infection to macrophage inflammation
Lucy Thorne, Ann‐Kathrin Reuschl, Lorena Zuliani‐Alvarez, et al.
The EMBO Journal (2021) Vol. 40, Iss. 15
Open Access | Times Cited: 203
Targeting the NLRP3 inflammasome in cardiovascular diseases
Stefano Toldo, Eleonora Mezzaroma, Leo F. Buckley, et al.
Pharmacology & Therapeutics (2021) Vol. 236, pp. 108053-108053
Open Access | Times Cited: 198
Page 1 - Next Page

Scroll to top